Want to see AU:AHF full AI Analyst Report?
Top Page
Australian Dairy Nutritionals Group
(Sydney:AHF)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.02
▼(-55.00% Downside)
Action:Reiterated
Date:08/29/26
The score is primarily constrained by weak financial performance—ongoing losses (including negative gross profit) and continued cash burn—despite relatively low balance sheet leverage. Technicals are mixed with a still-bearish longer-term trend (below 100/200-day averages and negative MACD), while valuation is also pressured by the negative P/E and lack of dividend yield data.
Positive Factors
Low Balance Sheet Leverage
Low leverage limits interest and refinancing pressure, giving the company more flexibility to fund its turnaround. This is an important financial cushion while management works to restore profitability and positive cash generation.
Negative Factors
Structural Unprofitability
Negative gross profit means the core products are not currently covering their direct costs, while deep operating losses show limited cost absorption. Without a durable margin recovery, growth would not translate into sustainable shareholder value.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Balance Sheet Leverage
Low leverage limits interest and refinancing pressure, giving the company more flexibility to fund its turnaround. This is an important financial cushion while management works to restore profitability and positive cash generation.
Read all positive factors
Australian Dairy Nutritionals Group (AHF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$14.17M
Dividend YieldN/A
Average Volume (3M)269.93K
Price to Earnings (P/E)―
Beta (1Y)0.27
Revenue Growth0.46%
EPS Growth46.48%
CountryAU
Employees51
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding787,431,300
10 Day Avg. Volume288,684
30 Day Avg. Volume269,929
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.62
Price to Sales (P/S)1.92
P/FCF Ratio-3.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Australian Dairy Nutritionals Group Business Overview & Revenue Model
Company Description
Australian Dairy Nutritionals Group operates as a fully integrated enterprise specializing in the production of dairy products throughout Australia. The company's activities are organized into two main divisions: Dairy Farms and Dairy Processing. ...
Australian Dairy Nutritionals Group Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
63
Positive
Cash Flow
27
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.07M | 7.17M | 6.18M | 5.86M | 5.80M |
| Gross Profit | -3.11M | -1.42M | -2.15M | -288.23K | -4.36M |
| EBITDA | -3.13M | -4.30M | -6.26M | -5.95M | -1.29M |
| Net Income | -2.84M | -5.21M | -7.36M | -9.16M | -4.15M |
Balance Sheet | |||||
| Total Assets | 25.22M | 25.09M | 30.35M | 36.24M | 44.60M |
| Cash, Cash Equivalents and Short-Term Investments | 1.16M | 2.69M | 6.13M | 2.01M | 2.43M |
| Total Debt | 1.62M | 48.45K | 2.25M | 1.04M | 1.09M |
| Total Liabilities | 3.48M | 1.44M | 3.62M | 2.72M | 4.65M |
| Stockholders Equity | 21.74M | 23.85M | 26.87M | 33.59M | 16.05M |
Cash Flow | |||||
| Free Cash Flow | -4.27M | -3.46M | -4.72M | -7.91M | -6.90M |
| Operating Cash Flow | -3.79M | -3.28M | -4.44M | -7.05M | -3.80M |
| Investing Cash Flow | -294.21K | -47.59K | 6.73M | 6.18M | 3.10M |
| Financing Cash Flow | 2.55M | -94.51K | 1.80M | 449.98K | -3.07M |
Australian Dairy Nutritionals Group Technical Analysis
Positive
0.04
Price Trends
0.02
Positive
0.02
Negative
0.02
Negative
Market Momentum
<0.01
Negative
56.63
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Positive. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.63 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHF.
Australian Dairy Nutritionals Group Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | AU$145.29M | 16.35 | 12.22% | 2.27% | 27.60% | 96.31% | |
63 Neutral | AU$1.86B | 34.62 | 5.46% | 1.95% | 6.66% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
48 Neutral | AU$78.68M | -18.27 | -11.08% | ― | 9.08% | -183.87% | |
46 Neutral | AU$13.33M | -1.79 | -88.51% | ― | 11.96% | -81.99% | |
43 Neutral | AU$14.17M | -4.47 | -12.90% | ― | 0.46% | 46.48% | |
39 Underperform | AU$6.99M | -0.01 | 226.76% | ― | -32.83% | 83.37% |
* Consumer Defensive Sector Average
AU:AHF
Australian Dairy Nutritionals Group
0.02
-0.02
-57.14%
AU:BGA
Bega Cheese Limited
6.11
0.49
8.72%
AU:BUB
Bubs Australia Ltd.
0.09
-0.07
-41.88%
AU:NUC
Nuchev Pty Ltd
0.09
-0.06
-43.33%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
<0.01
16.67%
AU:CLV
Clover Corporation Limited
0.89
0.33
60.62%
Australian Dairy Nutritionals Group Corporate Events
Australian Dairy Nutritionals Updates ASX Corporate Governance Disclosures
Aug 27, 2026
Australian Dairy Nutritionals Group has released its updated corporate governance statement for the financial year ended 30 June 2026, confirming it is current as of 27 August 2026 and approved by the board of directors. The statement, available v...
Australian Dairy Nutritionals Narrows Losses but Faces Going-Concern Warning
Aug 27, 2026
Australian Dairy Nutritionals Group reported revenue from ordinary activities of $7.15 million for the year ended 30 June 2026, essentially flat compared with the prior year. However, its loss from ordinary activities after tax narrowed significan...
Australian Dairy Nutritionals boosts powder sales as China and Vietnam drive growth shift
Jul 30, 2026
Australian Dairy Nutritionals reported Q4 FY26 consolidated revenue of $2.6m, up 90% on the prior quarter but slightly down year on year, driven by strong growth in nutritional powder sales to $2.1m and expanding distribution of its Future brand i...
Australian Dairy Nutritionals Director Wenjun Zhang Steps Down, Retains Indirect Stake
Jul 10, 2026
Australian Dairy Nutritionals Group has announced that director Wenjun Zhang ceased to be a board member on 6 July 2026. The notice, lodged with the ASX, confirms that Zhang held no securities as a registered holder but had an indirect interest th...
Australian Dairy Nutritionals Adds New Director With No Current Shareholding
Jul 6, 2026
Australian Dairy Nutritionals Limited has appointed Daniel Espie as a director effective 6 July 2026, marking a change in the company’s board composition. According to the initial director’s interest notice lodged with the ASX, Espie c...
Australian Dairy Nutritionals reshapes board and appoints China-focused executive to drive growth
Jun 24, 2026
Australian Dairy Nutritionals Limited has reshaped its leadership team, appointing experienced food and dairy executive Daniel Espie as an independent non-executive director from 6 July 2026 and transitioning current non-executive director Wenjun ...
Australian Dairy Nutritionals Fast-Tracks Amended Long-Term Incentive Plan
Jun 16, 2026
Australian Dairy Nutritionals Limited has approved an amended Long Term Incentive Plan aimed at providing structured equity incentives to eligible participants and aligning their interests with shareholders. The plan is designed to support the com...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.